These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23460283)

  • 21. Effects of third-generation β-blockers, atenolol or amlodipine on blood pressure variability and target organ damage in spontaneously hypertensive rats.
    Del Mauro JS; Prince PD; Allo MA; Santander Plantamura Y; Morettón MA; González GE; Bertera FM; Carranza A; Gorzalczany SB; Chiappetta DA; Morales C; Gelpi RJ; Taira CA; Polizio AH; Donato M; Höcht C
    J Hypertens; 2020 Mar; 38(3):536-545. PubMed ID: 32028517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats.
    Toblli JE; Cao G; Casas G; Mazza ON
    Am J Hypertens; 2006 Dec; 19(12):1226-32. PubMed ID: 17161767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction.
    Pires MJ; Rodríguez-Peña AB; Arévalo M; Cenador B; Evangelista S; Esteller A; Sánchez-Rodríguez A; Colaço A; López-Novoa JM
    J Hypertens; 2007 Dec; 25(12):2486-96. PubMed ID: 17984671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute effects of third generation β-blockers on short-term and beat-to-beat blood pressure variability in sinoaortic-denervated rats.
    Bertera FM; Del Mauro JS; Lovera V; Chiappetta D; Polizio AH; Taira CA; Höcht C
    Hypertens Res; 2013 Apr; 36(4):349-55. PubMed ID: 23364340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.
    De Crée J; Cobo C; Geukens H; Verhaegen H
    Angiology; 1990 Feb; 41(2):95-105. PubMed ID: 1968323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological properties of nebivolol in man.
    Van Bortel LM; de Hoon JN; Kool MJ; Wijnen JA; Vertommen CI; Van Nueten LG
    Eur J Clin Pharmacol; 1997; 51(5):379-84. PubMed ID: 9049578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nebivolol increases arterial distensibility in vivo.
    McEniery CM; Schmitt M; Qasem A; Webb DJ; Avolio AP; Wilkinson IB; Cockcroft JR
    Hypertension; 2004 Sep; 44(3):305-10. PubMed ID: 15262912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nebivolol: comparison of the effects of dl-nebivolol, d-nebivolol, l-nebivolol, atenolol, and placebo on exercise-induced increases in heart rate and systolic blood pressure.
    Van Nueten L; De Crée J
    Cardiovasc Drugs Ther; 1998 Sep; 12(4):339-44. PubMed ID: 9825177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacology of nebivolol.
    Janssens WJ
    J Pharm Belg; 1992; 47(4):323-7. PubMed ID: 1357130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nebivolol is more effective than atenolol for blood pressure variability attenuation and target organ damage prevention in L-NAME hypertensive rats.
    Del Mauro JS; Prince PD; Santander Plantamura Y; Allo MA; Parola L; Fernandez Machulsky N; Morettón MA; Bin EP; González GE; Bertera FM; Carranza A; Berg G; Taira CA; Donato M; Chiappetta DA; Polizio AH; Höcht C
    Hypertens Res; 2021 Jul; 44(7):791-802. PubMed ID: 33612826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats.
    Oelze M; Daiber A; Brandes RP; Hortmann M; Wenzel P; Hink U; Schulz E; Mollnau H; von Sandersleben A; Kleschyov AL; Mülsch A; Li H; Förstermann U; Münzel T
    Hypertension; 2006 Oct; 48(4):677-84. PubMed ID: 16940222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension.
    Ceron CS; Rizzi E; Guimarães DA; Martins-Oliveira A; Gerlach RF; Tanus-Santos JE
    Free Radic Biol Med; 2013 Dec; 65():47-56. PubMed ID: 23806385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in l-NAME-induced hypertensive rats.
    Wang Y; Zhang F; Liu Y; Yin S; Pang X; Li Z; Wei Z
    Clin Exp Hypertens; 2017; 39(7):628-639. PubMed ID: 28640644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does nebivolol influence serum concentrations of proinflammatory cytokines in hypertensive (SHR) and normotensive (WKY) rats?
    Górska D; Dudarewicz M; Czarnecka E; Andrzejczak D
    Pharmacol Rep; 2010; 62(1):86-94. PubMed ID: 20360618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nebivolol prevents myocardial fibrosis and diastolic dysfunction in salt-loaded spontaneously hypertensive rats.
    Susic D; Fares H; Frohlich ED
    J Am Soc Hypertens; 2012; 6(5):316-23. PubMed ID: 22995800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation.
    Kubli S; Feihl F; Waeber B
    Clin Pharmacol Ther; 2001 Apr; 69(4):238-44. PubMed ID: 11309552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nebivolol attenuates maladaptive proximal tubule remodeling in transgenic rats.
    Hayden MR; Habibi J; Whaley-Connell A; Sowers D; Johnson M; Tilmon R; Jain D; Ferrario C; Sowers JR
    Am J Nephrol; 2010; 31(3):262-72. PubMed ID: 20110666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol.
    Nodari S; Metra M; Dei Cas L
    Eur J Heart Fail; 2003 Oct; 5(5):621-7. PubMed ID: 14607201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salt-induced renal injury in spontaneously hypertensive rats: effects of nebivolol.
    Varagic J; Ahmad S; Brosnihan KB; Habibi J; Tilmon RD; Sowers JR; Ferrario CM
    Am J Nephrol; 2010; 32(6):557-66. PubMed ID: 21042014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular effects of dl-nebivolol and its enantiomers--a comparison with those of atenolol.
    Van de Water A; Xhonneux R; Reneman RS; Janssen PA
    Eur J Pharmacol; 1988 Oct; 156(1):95-103. PubMed ID: 3208842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.